Clinical trials
Completed Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,743 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 14 |
| 2002 | 19 |
| 2003 | 24 |
| 2004 | 27 |
| 2005 | 35 |
| 2006 | 51 |
| 2007 | 49 |
| 2008 | 51 |
| 2009 | 53 |
| 2010 | 70 |
| 2011 | 70 |
| 2012 | 82 |
| 2013 | 90 |
| 2014 | 98 |
| 2015 | 88 |
| 2016 | 74 |
| 2017 | 89 |
| 2018 | 117 |
| 2019 | 115 |
| 2020 | 108 |
| 2021 | 118 |
| 2022 | 83 |
| 2023 | 94 |
| 2024 | 51 |
| 2025 | 38 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,743 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 93 |
| Novartis Pharmaceuticals | 45 |
| Merck KGaA, Darmstadt, Germany | 35 |
| Bayer | 33 |
| Hasselt University | 28 |
| Gazi University | 26 |
| Sanofi | 22 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 20 |
| University of Washington | 18 |
| Kessler Foundation | 17 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 1,743 |
| Multiple Sclerosis, Relapsing-Remitting | 179 |
| Fatigue | 117 |
| Multiple Sclerosis, Chronic Progressive | 60 |
| Stroke | 46 |
| Spinal Cord Injuries | 44 |
| Muscle Spasticity | 37 |
| Recurrence | 36 |
| Autoimmune Diseases | 33 |
| Demyelinating Diseases | 32 |
Trials
Showing 26 to 50 of 1,743. Each trial links to its page on Pharma Observatory.
1,643 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.